The new book educates women about menopause, hormone replacement therapy and how testosterone will safely improve symptoms.
by Dr. Charles Mok
My new book focuses on setting the record straight and educating women about hormone replacement.
Recently, scientists have improved upon conventional hormone replacement therapy by adding testosterone.
They first found testosterone added to estrogen reduced the expected rates of breast cancer. Additionally, these women felt significant benefits by having their testosterone replaced. It relieved symptoms of menopause and perimenopause while contributing to better energy, sexuality, and strength.
In females, estrogen is made from testosterone and other androgens in the ovary. Which led to the idea that testosterone could also be used as a treatment by itself.
It was proven once again that testosterone protected women against breast cancer. In a large clinical trial of nearly 10 years, the studies showed a remarkable 75% reduction in the rate of breast cancer. Additionally, there were no adverse effects and all symptoms associated with perimenopause and menopause were reduced.
In my book, I review hundreds of clinical studies that lead to this discovery and present you with sound, scientific answers. Furthermore, the clinical history of hormone replacement therapy has an interesting story. In the 1940’s, estrogen was used for hormone imbalance. The source of the hormones was predominately from horses. PremarinⓇ was the main drug, a word derived from Pregnant Mare Urine.
By the mid 70’s statistics had shown that horse estrogen alone led to an increase in uterine cancer, so progesterone was added which eliminated that risk.
Then in the 1980’s, progesterone was replaced with a synthetic drug called progestin. In addition to horse estrogen, these drugs worked well to relieve symptoms of menopause and perimenopause. And for the next 20 years, they became the most common prescriptions for HRT in the United States.
But in 2002, the Women’s Health Initiative published a study that showed an increased risk in the rate of breast cancer for women taking PremarinⓇ and ProveraⓇ. This signaled a huge drop for all estrogen prescriptions.
Millions of women had abandoned their treatments. Although after the Women’s Health Initiative study evidence showed the real risk of breast cancer was due to the artificial hormone drugs being used — not estrogen or progesterone.
Today, with the recent studies about testosterone and estrogen, it’s becoming clear we had simply picked the wrong hormone to replace. The dominant sexual hormone in young, hormonally balanced women is actually testosterone. In fact, it’s ten-times more prominent in women than estrogen.
In my new book, we expand upon this history, where we stand today and what’s to come in the future. I see it as a contribution to the medical community and great way to teach patients about this safe and effective hormone treatment.
As always at Allure Medical, we’re continually staying on the cusp of new medical procedures and clinical studies. It’s all part of our mission to help patients live a healthier and better life.
Charles Mok, D.O.